Skip to main content
Shlomo Melmed, MD, Endocrinology, Los Angeles, CA

ShlomoMelmedMD

Endocrinology Los Angeles, CA

Diabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology

Professor and Dean

Dr. Melmed is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Melmed's full profile

Already have an account?

  • Office

    8700 Beverly Blvd
    Los Angeles, CA 90048
    Phone+1 310-423-2830
    Fax+1 310-423-2819

Education & Training

  • UCLA-VA Greater Los Angeles
    UCLA-VA Greater Los AngelesFellowship, Endocrinology, Diabetes, and Metabolism, 1977 - 1980
  • UCLA-VA Greater Los Angeles
    UCLA-VA Greater Los AngelesResidency, Internal Medicine, 1977 - 1980
  • University of Cape Town Faculty of Medicine
    University of Cape Town Faculty of MedicineClass of 1970

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1979 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • Top Doctors:LA Area Castle Connolly, 2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Consensus Statement on Acromegaly Therapeutic Outcomes  
    David R Clemmons, Shlomo Melmed, Anne Klibanski, Nature

Lectures

  • Pituitary-Tumor Endocrinopathies 
    ENDO 2019 - New Orleans, LA - 3/25/2019
  • Optimizing Health Outcomes in Acromegaly: Comorbidity and Cancer Surveillance Beyond IGF-1 (Repeat) 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Optimizing Health Outcomes in Acromegaly: Comorbidity and Cancer Surveillance Beyond IGF-1 
    ENDO 2019 - New Orleans, LA - 3/24/2019

Other

Authored Content

  • Pituitary-Tumor EndocrinopathiesMarch 2020

Press Mentions

  • Urologic Oncologist Hyung Kim, MD, Named Chair of Cedars-Sinai Department of Urology
    Urologic Oncologist Hyung Kim, MD, Named Chair of Cedars-Sinai Department of UrologyFebruary 2nd, 2023
  • May Research Highlights: A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-Sinai
    May Research Highlights: A Roundup of the Latest Medical Discoveries and Faculty News at Cedars-SinaiMay 26th, 2022
  • COVID Risk in T1D; Lilly to Drop Some Insulin Prices; New ADA/EASD T1D Guideline
    COVID Risk in T1D; Lilly to Drop Some Insulin Prices; New ADA/EASD T1D GuidelineOctober 3rd, 2021
  • Join now to see all

Grant Support

  • GHNIDDKPresent

Professional Memberships